GDF2 anticorps (AA 351-429) (Cy5)
Aperçu rapide pour GDF2 anticorps (AA 351-429) (Cy5) (ABIN885271)
Antigène
Voir toutes GDF2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 351-429
-
Réactivité croisée
- Humain, Souris, Rat
-
Homologie
- Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human BMP9
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- GDF2 (Growth Differentiation Factor 2 (GDF2))
-
Autre désignation
- BMP9
-
Sujet
-
Synonyms: BMP9, HHT5, BMP-9, Growth/differentiation factor 2, GDF-2, Bone morphogenetic protein 9, GDF2
Background: Potent circulating inhibitor of angiogenesis. Could be involved in bone formation. Signals through the type I activin receptor ACVRL1 but not other Alks. Signaling through SMAD1 in endothelial cells requires TGF-beta coreceptor endoglin/ENG.
-
ID gène
- 2658
-
UniProt
- Q9UK05
-
Pathways
- Transition Metal Ion Homeostasis
Antigène
-